Global Laboratory Network Eurofins Biopharma Product Testing's extensive network of 37 laboratories across Europe, North America, Asia, and Oceania offers a broad geographical reach for clients, enabling convenient access to specialized testing and validation services in multiple regions.

Comprehensive Testing Capabilities The company's wide range of analytical services, including chemical, biochemical, microbiological testing, and biosafety assessments, positions it as a one-stop partner for bio/pharmaceutical companies seeking end-to-end testing solutions.

Strategic Acquisitions & Expansion Recent acquisitions and investments, such as the purchase of labs in France and the acquisition of Transplant Genomics, demonstrate Eurofins' commitment to expanding its testing portfolio and strengthening its presence in specialized clinical testing markets.

Industry Focus & Compliance Specializing in GMP-compliant environments and adhering to major pharmacopoeia standards, Eurofins' expertise aligns well with clients requiring rigorous quality and regulatory compliance for drug development, manufacturing, and validation processes.

Growth & Market Position With revenue estimates between one to ten million dollars and a track record of strategic investments, Eurofins offers potential sales partners opportunities to collaborate in expanding service offerings and capturing new client segments in the pharmaceutical testing industry.